The profits may then be reinvested or spent, creating significant stimulativeeffects, but usually this happens when market conditions are strong, exacerbating unsustainable market booms.
By delivering another blow to American drug and medical device companies already reeling from the effects of excessive and unwise regulation, it will actually be anti-stimulative.